Journal-Based CME: The PML Hub: An Emerging Actor of Leukemia Therapies
Journal CME
1 AMA PRA Category 1 Credit™ OVERVIEW
Journal-Based CME: The PML hub: An emerging actor of leukemia therapies is organized by Memorial Sloan Kettering Cancer Center (MSKCC).
Recorded/Review Date: June 29, 2023
Original Release Date: June 29, 2023
Termination Date: June 29, 2026
Description:
This Journal-Based CME activity consists of a full-text article that is free to read, a multiple-choice question test, and an evaluation/self-assessment. Learners are tested on their comprehension of the key concepts, with the objective of enriching their clinical practice and patient care through better understanding of scientific advances and new techniques in the fields covered by Journal of Experimental Medicine (JEM).
Questions for this complimentary, online-only activity have been designed by JEM editors in collaboration with the article authors. Each CME activity should take approximately 1 hour to complete.
The article selected for this activity is “The PML hub: An emerging actor of leukemia therapies,” by Domitille Rérolle and Hugues de Thé of the Center for Interdisciplinary Research in Biology, Collège de France, Inserm, PSL Research University in Paris, France.
ACCREDITATION & CREDITS
Accreditation
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Memorial Sloan Kettering Cancer Center, the Journal of Experimental Medicine (JEM) and Rockefeller University Press. Memorial Sloan Kettering Cancer Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
AMA Credit Designation Statement
Memorial Sloan Kettering Cancer Center designates this enduring material for a maximum of 1.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
TARGET AUDIENCE
PhysicianOncologyBreast CancerHematologistSurgical OncologistsPediatricsNurse PractitionersNeuro-OncologistsRadiation OncologistsMedical OncologistsSPECIALITIES
General PracticeFamily PracticeLaboratory MedicineMedical OncologyMolecular BiologyNurse PractitionerOncologyPathologyPediatricsRadiation OncologySurgical OncologyPediatric Hematology and Bone Marrow TransplantHematology Blood and Marrow TransplantPharmacologyGynecologic OncologyHead and Neck PathologyImmunotherapiesRELATED ONLINE COURSES
Quick Links